Antimicrobial Treatment in New and Old Difficult to Treat Infectious Diseases
A special issue of Microorganisms (ISSN 2076-2607). This special issue belongs to the section "Antimicrobial Agents and Resistance".
Deadline for manuscript submissions: closed (30 April 2021) | Viewed by 3658
Special Issue Editors
Interests: immunology; antimicrobials; HIV; antimicrobial stewardship; public health
Special Issues, Collections and Topics in MDPI journals
Interests: HIV; antimicrobial stewardship; clinical microbiology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Antimicrobial resistance is the ability of a microorganism to resist the action of an antimicrobial agent. The major contributor to the spread of antimicrobial resistance is their use in human medicine. Antimicrobial resistance surveillance should provide data about the need and appropriateness of therapy guidelines, formularies, antimicrobial stewardship programs, public health interventions, infection control policies and antimicrobial development.
At this very moment, SARS-CoV-2 monopolizes the world attention. We seem to have forgotten that difficult to treat infectious diseases, and especially bacterial ones, will cause more than 10 million deaths by 2050. Therefore, we think that it is important to focus again on this matter of utmost importance, since difficult to treat infectious diseases are not disappearing because of SARS-CoV-2, and this lowering of the threshold of attention might have consequences regarding the increasing rates of antimicrobial resistances.
We want this issue to focus on research both regarding antimicrobial resistance rates, new and old therapeutic schemes and new and old mechanisms of resistance, hoping to deliver important information that will help contrasting difficult to treat infectious diseases.
Prof. Giuseppe Nunnari
Dr. Manuela Ceccarelli
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antimicrobial stewardship
- antimicrobial resistance
- public health
- difficult to treat infectious diseases
- multi-drug resistance
- mechanisms
- bacterial infectious diseases
- fungal infectious diseases
